CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

GlobeNewswire Pharma
Original article

VIRBAC: A robust adjusted EBIT margin² of 18.8%, driven by solid organic revenue growth of 7.4%

EarningsPositive
AI Analysis

Summary

Virbac reported H1 2026 results with a 7.4% organic revenue growth and an adjusted EBIT margin of 18.8%, reflecting solid operational performance.

Financial Highlights

Revenue

7.4% organic growth

Importance:3/10
Sentiment:
0.60
earningsorganic growthprofitability
Related Companies

Read the original article

Published by GlobeNewswire Pharma on September 17, 2026 3:45 PM

Read Original